Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

Share Price is delayed by 15 minutes
Get Live Data
14,318.00    256.00 (1.82%)
Bid:
14,256.00
Ask:
14,262.00
Spread: 6.00 (0.042%)
Market Cap: £222.05b
AZN Live PriceLast checked at - London Stock Exchange

Intraday Astrazeneca Share Chart

Astrazeneca News

AstraZeneca CEO says company has no access to executive Wang, in detention in China
6 Feb 2025

AstraZeneca CEO says company has no access to executive Wang, in detention in China

LONDON, Feb 6 (Reuters) - AstraZeneca has been approached a couple of times by Chinese authorities about their investigation into the drugmaker's fo...

Cancer drugs help drive fourth-quarter sales beat at AstraZeneca
6 Feb 2025

Cancer drugs help drive fourth-quarter sales beat at AstraZeneca

(Alliance News) - AstraZeneca PLC on Thursday ended a strong year with better-than-expected fourth quarter earnings and said its pipeline would suppor...

LONDON MARKET OPEN: Risk appetite returns ahead of BoE decision
6 Feb 2025

LONDON MARKET OPEN: Risk appetite returns ahead of BoE decision

(Alliance News) - Stock prices in London opened higher on Thursday, with the absence of new tariff salvos boosting risk appetite, while the pound fade...

Revenues, profits surge at AstraZeneca
6 Feb 2025

Revenues, profits surge at AstraZeneca

(Sharecast News) - AstraZeneca posted forecast-beating numbers on Thursday, fuelled by strong demand for its cancer and cardiometabolic drugs.

LONDON BRIEFING: AstraZeneca profit up; BBGI backs GBP1.1 billion bid
6 Feb 2025

LONDON BRIEFING: AstraZeneca profit up; BBGI backs GBP1.1 billion bid

(Alliance News) - London's FTSE 100 is called to open higher on Thursday, with risk appetite returning after a week which has so far been marred by tr...

IN BRIEF: Indivior completes USD100 million share buyback
4 Feb 2025

IN BRIEF: Indivior completes USD100 million share buyback

Indivior PLC - Richmond, Virginia-based maker of medicines to treat substance use disorders - Completes share buyback programme begun in July. Indivio...

AstraZeneca's Imfinzi endorsed for EU approval for lung cancer care
3 Feb 2025

AstraZeneca's Imfinzi endorsed for EU approval for lung cancer care

(Alliance News) - AstraZeneca PLC on Monday said Imfinzi has been recommended for approval in the EU as monotherapy for limited-stage small cell lung ...

LONDON BRIEFING: Astra gets EU committee boost; SigmaRoc confident
3 Feb 2025

LONDON BRIEFING: Astra gets EU committee boost; SigmaRoc confident

(Alliance News) - European equities are set to tumble at the start of the week, while the dollar powered higher after US President Donald Trump impose...